SABREENA GUNN: Open Payments
NPI 1386284016 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 15 payments from 10 companies in 2025. Trend: 2023 $583 · 2024 $526 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 2 | $165 |
| ABIOMED | 1 | $134 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $58 |
| ABBVIE INC. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $39 |
| Ferring Pharmaceuticals Inc. | 1 | $28 |
| Blue Earth Diagnostics | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| COLOPLAST CORP | 1 | $14 |
Products named: XIAFLEX, Nubeqa, LUPRON DEPOT, Xtandi, ADSTILADRIN, AVEED, POSLUMA, ERLEADA.
Industry payments across VA — which companies pay providers there.
